Fomivirsen (brand name Vitravene) is an antiviral drug. It is used in the treatment
of cytomegalovirus retinitis (CMV) in immunocompromised patients, including ...
Vitravene† (fomivirsen sodium intravitreal injectable) is a sterile, aqueous,
preservative-free, bicarbonate-buffered solution for intravitreal injection.
Fomivirsen Sodium Drug Information from Drugs.com. Includes Fomivirsen
Sodium side effects, interactions and indications.
Apr 10, 2002 ... Vitravene (Fomivirsen Sodium Intravitreal Injectable) Injection Company: Isis
Pharmaceuticals, Inc. Application No.: 20-961. Approval Date: ...
Aug 6, 2002 ... VITRAVENE (fomivirsen). WITHDRAWAL OF THE MARKETING
AUTHORISATION IN THE EUROPEAN UNION. On 29 July 1999 the European ...
A human cytomegalovirus mutant that was isolated for resistance (10-fold) to the
antisense oligonucleotide fomivirsen (ISIS 2922) exhibited cross-resistance to a ...
Fomivirsen, previously known as ISIS 2922, is an approved second-line
treatment for cytomegalovirus (CMV) retinitis that is injected into the eye.
Since fomivirsen blocks CMV from replicating through a different mechanism than
that of other approved CMV retinitis therapies, people who have developed ...
Apr 1, 2015 ... Fomivirsen is an antiviral medicine that is injected into the eye (intravitreal). It is
used to treat a serious condition called cytomegalovirus (CMV) ...
Oct 10, 2012 ... Fomivirsen (ISIS 2922) is an antisense oligonucleotide which specifically inhibits
replication of human cytomegalovirus. It achieves this by ...